COO vs. EW: Cooper vs. Edwards Lifesciences Stock Comparison
How do Cooper (COO) and Edwards Lifesciences (EW) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Cooper (COO) and Edwards Lifesciences (EW) both belong to the Health Care Equipment & Supplies industry, though COO is classified under Health Care Supplies while EW falls under Health Care Equipment.
| Profile Item | COO | EW |
|---|---|---|
| Name | The Cooper Companies, Inc. | Edwards Lifesciences Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Supplies | Health Care Equipment |
| Market Capitalization | 11.86 billion USD | 58.73 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | January 21, 1983 | March 27, 2000 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | COO | EW |
|---|---|---|
| Total Return (1Y) | -9.72% | 25.08% |
| Total Return (3Y, Annualized) | -8.06% | 17.28% |
| Total Return (5Y, Annualized) | -10.20% | -2.77% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | COO | EW |
|---|---|---|
| Volatility (1Y, Annualized) | 32.67% | 25.58% |
| Beta (5Y) | 0.79 | 0.78 |
| Max Drawdown (5Y) | -52.11% | -54.32% |
| Avg. Volume (3M) | 3.47M | 3.69M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | COO | EW |
|---|---|---|
| Sharpe Ratio (1Y) | -0.43 | 0.81 |
| Sortino Ratio (1Y) | -0.59 | 1.23 |
Profitability
ROE (TTM)
Both Cooper (COO) at 6.84% and Edwards Lifesciences (EW) at 9.33% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
COO
Health Care Equipment & Services industry group
6.84%
- Max
- 47.61%
- Q3
- 14.36%
- COO
- 6.84%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Cooper (COO) at 13.46% and Edwards Lifesciences (EW) at 15.30% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
COO
Health Care Equipment & Services industry group
13.46%
- Max
- 29.35%
- COO
- 13.46%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Cooper (COO) at 20.82% and Edwards Lifesciences (EW) at 30.15% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
COO
Health Care Equipment & Services industry group
20.82%
- Max
- 35.43%
- COO
- 20.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | COO | EW |
|---|---|---|
| ROE (TTM) | 6.84% | 9.33% |
| ROA (TTM) | 2.74% | 8.77% |
| Net Margin (TTM) | 13.46% | 15.30% |
| Operating Margin (TTM) | 20.82% | 30.15% |
| Gross Margin (TTM) | 65.93% | 78.02% |
Growth
Revenue Growth
Both Cooper (COO) at 5.06% and Edwards Lifesciences (EW) at 11.55% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Cooper (COO) at -4.59% is around its peer norm for EPS growth, while Edwards Lifesciences (EW) at -73.74% drops into the bottom quartile, signaling weaker earnings momentum.
Growth Metrics
| Metric | COO | EW |
|---|---|---|
| Revenue Growth (YoY) | 5.06% | 11.55% |
| Revenue Growth (3Y CAGR) | 7.35% | 10.77% |
| EPS Growth (YoY) | -4.59% | -73.74% |
| EPS Growth (3Y CAGR) | -1.22% | -9.14% |
Financial Strength
Current Ratio (MRQ)
Edwards Lifesciences (EW) at 4.60 carries current ratio above its industry’s typical mid-range, while Cooper (COO) at 1.22 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.
COO
Health Care Equipment & Services industry group
1.22
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- COO
- 1.22
- Min
- 0.30
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower industry quartile, while Cooper (COO) at 0.34 runs a more typical debt-to-equity mix.
COO
Health Care Equipment & Services industry group
0.34
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- COO
- 0.34
- Q1
- 0.16
- Min
- 0.00
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
Financial Strength Metrics
| Metric | COO | EW |
|---|---|---|
| Current Ratio (MRQ) | 1.22 | 4.60 |
| Debt / Equity (MRQ) | 0.34 | 0.06 |
| Net Debt / EBITDA | 2.84 | -1.88 |
Dividends
Dividend Yield (TTM)
Neither Cooper (COO) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
COO
Health Care Equipment & Services industry group
0.00%
- COO
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Cooper (COO) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
COO
Health Care Equipment & Services industry group
0.00%
- COO
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | COO | EW |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Cooper (COO) at 21.43 is near its industry’s usual P/E ratio, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — EW needs stronger growth or earnings quality to justify the premium.
COO
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- COO
- 21.43
- Q1
- 21.19
- Min
- 4.21
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Cooper (COO) at 2.80 is priced about in line with its industry on P/S ratio, while Edwards Lifesciences (EW) at 8.80 sits in the pricier quartile — EW costs more per dollar of sales.
COO
Health Care Equipment & Services industry group
2.80
- Max
- 8.80
- Q3
- 4.32
- COO
- 2.80
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Cooper (COO) at 1.42 sits in the lower P/B ratio quartile against book while Edwards Lifesciences (EW) at 5.41 is valued near its industry’s middle — COO is cheaper on assets, though weigh it against ROE and asset quality.
COO
Health Care Equipment & Services industry group
1.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- COO
- 1.42
- Min
- -1.31
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | COO | EW |
|---|---|---|
| P/E Ratio (TTM) | 21.43 | 59.38 |
| P/S Ratio (TTM) | 2.80 | 8.80 |
| P/B Ratio (MRQ) | 1.42 | 5.41 |
| Free Cash Flow Yield (TTM) | 4.58% | 1.95% |